
Pacific Biosciences Posts Encouraging Quarterly Results
PacBio reported results that were in line with our expectations but slightly ahead of consensus. Revenue was $9.1 million, relative to our estimate of $9.8 million and consensus of $8.8 million, and loss per share was $0.26, relative to our estimate and consensus of loss per share of $0.28. The company booked orders for 9 PacBio RS systems in the quarter (versus our estimate of … Continue reading Pacific Biosciences Posts Encouraging Quarterly Results